ClinicalTrials.gg
Not yet recruitingNCT07067671ReVENtSUpdated Feb 19, 2026

Regional Ventilation Evaluation During Neuro-injury Weaning Study

An observational study in Acute Brain Injury, Mechanical Ventilation and Prolonged Weaning, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-19.

Primary conditionBrain Injuries, TraumaticRegistry: Brain InjuriesReclassifiedWhy we changed it
Registry
Brain Injuries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Brain Injuries, Traumatic
Why
  1. The study's listed conditions name Brain Injuries, Traumatic, a narrower term within Brain Injuries.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris — 6 open to participants now, 7 under way, none of them phase 3. Brain Injuries, Traumatic · Assistance Publique - Hôpitaux de Paris.

Started
2026
with 1 other
Observational
7 of 15
4 open now
Registered
14th of 15
by date

Among the 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris, this one is one of 2 that started in 2026, is one of 7 observational ones, and was the 14th registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

6 of the 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

This study evaluates changes in regional lung ventilation using thoracic electrical impedance tomography (EIT) during the weaning process from mechanical ventilation in ICU patients with acute brain injury. It aims to identify predictive EIT patterns related to extubation outcomes.

Read the detailed description

This is a prospective, single-center pilot study conducted in the intensive care unit. The study focuses on adult patients with acute brain injury requiring invasive mechanical ventilation for more than 48 hours. The aim is to assess regional alveolar ventilation using thoracic electrical impedance tomography (EIT) during different stages of ventilator weaning, including changes in ventilatory mode, spontaneous breathing trials, and, when feasible, around extubation or decannulation.

EIT provides dynamic, non-invasive real-time imaging of regional pulmonary ventilation. Data will be collected using a 16-electrode thoracic belt and analyzed retrospectively with dedicated software. The primary outcome measure is the Absolute Ventral-to-Dorsal Ventilation Difference, calculated from predefined regions of interest. Secondary outcomes include correlations with traditional ventilatory parameters (tidal volume, respiratory rate, oxygen saturation), end-expiratory impedance variation (ΔEELI), compliance changes, and extubation or decannulation failure defined by the need for reintubation within 7 days.

This study aims to improve understanding of regional ventilation patterns in brain-injured patients and assess the potential of EIT to predict weaning outcomes and guide personalized ventilatory strategies.

03

Conditions studied

  • Acute Brain Injury
  • Mechanical Ventilation
  • Prolonged Weaning
  • Traumatic Brain Injury
  • Hypoxic-Ischemic Brain Injury
  • Intracerebral Hemorrhage

Keywords

  • Electrical Impedance Tomography
  • Ventilator Weaning
  • Neurocritical Care
  • ICU Monitoring
  • Spontaneous Breathing Trial
  • Extubation Failure
  • Respiratory Mechanics
  • PulmoVista
  • EIT
  • Brain-Injured Patients
04

In context

Brain Injuries, Traumatic Reclassified

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

This study's planned enrollment of 60 is below the median of 116 across 558 observational studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.

Compared within Brain Injuries, Traumatic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Brain Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients hospitalized in intensive care for an acute brain injury under invasive mechanical ventilation for more than 48 hours.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older
  • Hospitalized in intensive care for an acute brain injury.
  • Mechanical ventilation for more than 48 hours.
  • Ventilator withdrawal planned in the next few days
  • Social security coverage

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Moribund patient / decision to stop treatment
  • Patient under state medical aid
06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Interventions

  • OtherInternal Thoracic Impedance

    Internal Thoracic Impedance is a non-invasive an imaging technique which use low alternative current through electrodes placed on a belt positioned at the level of the patient's rib cage. Images are constructed according to conductivity measured.

07

What researchers measure

Primary outcomes

  1. Absolute ventral-to-dorsal ventilation difference

    The Absolute V-D Difference will be calculated as the average of the ventilation in the ventral regions (ROI1 and ROI2) minus the average of the ventilation in the dorsal regions (ROI3 and ROI4) during mechanical ventilation weaning. This outcome will provide insights into regional pulmonary ventilation distribution and its correlation with extubation outcomes. This difference is calculated as follows: (ROI\_Value1 + ROI\_Value2)/2 - (ROI\_Value3 + ROI\_Value4)/2 expressed as a percentage.

    Time frame: From the start of the ventilator mode change or spontaneous breathing trial until 30 minutes after.

Secondary outcomes

  1. Correlation between Absolute V-D Difference and Conventional Ventilatory Parameters

    This outcome will evaluate how the Absolute V-D Difference correlates with other monitoring parameters, such as tidal volume, respiratory rate, SpO₂, and end-tidal CO₂ (EtCO₂), throughout the weaning process.

    Time frame: From the start of the ventilator mode change or spontaneous breathing trial until 30 minutes after

  2. End-Expiratory Lung Impedance (ΔEELI)

    The monitoring of ΔEELI will be continuous throughout the spontaneous breathing trial, which lasts 30 minutes. Monitoring will begin at a stable baseline 5 minutes prior to the start of the trial and will continue until 5 minutes after its completion. Three specific time points will be collected and analyzed: 1. EELI before the trial (baseline, 5 minutes prior), 2. EELI at the end of the trial (30 minutes), 3. EELI 5 minutes after resumption of mechanical ventilation

    Time frame: From 5 minutes before to 5 minutes after the 30-minute spontaneous breathing trial (i.e., total duration of 40 minutes)

  3. Correlation between ΔEELI and Extubation/Decannulation Failure

    This secondary outcome assesses the relationship between changes in end-expiratory impedance (ΔEELI) and extubation or decannulation failure, defined as reintubation or need for reventilation within 7 days.

    Time frame: 7 days post-extubation or post-deventilation.

  4. Pulmonary Compliance Variation during Ventilator Changes and Spontaneous Breathing Trials

    This measure will track the changes in regional pulmonary compliance in response to adjustments in ventilator parameters (e.g., PEEP, tidal volume) and spontaneous breathing trials.

    Time frame: From the start of ventilator mode change or spontaneous breathing trial until 30 minutes after.

  5. Absolute V-D Difference and Extubation Failure

    This outcome will examine the correlation between the Absolute V-D Difference and extubation failure, defined as reintubation or the need for reventilation within 7 days post-extubation or post-deventilation.

    Time frame: 7 days post-extubation or post-deventilation.

08

Study locations

1 site
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Mar 2028, 24 months later.

Of 231 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 95. This study's planned 24 months is below that.

Counting every sponsor, half of 253 studies reached it within 49 months; a quarter within 23 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2025
First posted
Jul 16, 2025
StartEst.
Mar 2026
Primary completionEst.
Mar 2028
CompletionEst.
Mar 2028
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07067671
Responsible party
Sponsor
First posted
Jul 16, 2025
Start date
Mar 2026 (estimated)
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Feb 19, 2026

Study contacts

Samuel Gaugain, MD
Contact
samuel.gaugain@aphp.fr
+330149958518
Benjamin Chousterman, MD PhD
Contact
benjamin.chousterman@aphp.fr
+330149958518
Samuel Gaugain, MD
principal investigator · APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion